Clinical Trials Logo

Clinical Trial Summary

This proposal will focus on (1) estimating oxidative capacity of specific muscle groups during exercise using near infrared spectroscopy and (2) describing body composition to better understand exercise capacity and mitochondrial function in ambulatory spinal muscular atrophy (SMA) patients and disease controls. It is a 6-month observational study including 14 ambulatory SMA patients, 14 ambulatory patients with mitochondrial myopathy, and 14 healthy controls.

Clinical Trial Description

Spinal Muscular Atrophy (SMA) is a progressive, recessively-inherited neuromuscular disease characterized by weakness and muscle atrophy due to the loss of spinal cord motor neurons. The results from this study would provide preliminary data, using non-invasive methods, on oxidative capacity in ambulatory SMA patients and disease controls to aid in the design of exercise intervention studies. Furthermore, this information would link previous laboratory and preclinical findings of mitochondrial depletion in SMA to the clinical condition and provide important information for future studies designed to improve oxidative capacity and fitness in SMA patients. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT02895789
Study type Observational
Source Columbia University
Contact Ashley Goodwin
Phone 212-305-8916
Status Recruiting
Start date November 2016
Completion date May 2020

See also
  Status Clinical Trial Phase
Recruiting NCT02227823 - Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3 Phase 2
Recruiting NCT03709784 - Spinraza in Adult Spinal Muscular Atrophy
Terminated NCT03056144 - Whole Body Vibration Therapy in Children With Spinal Muscular Atrophy N/A
Recruiting NCT03921528 - An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ) Phase 2